Vulnerability Details : CVE-2023-33255
Potential exploit
An issue was discovered in Papaya Viewer 1.0.1449. User-supplied input in form of DICOM or NIFTI images can be loaded into the Papaya web application without any kind of sanitization. This allows injection of arbitrary JavaScript code into image metadata, which is executed when that metadata is displayed in the Papaya web application.
Products affected by CVE-2023-33255
- cpe:2.3:a:uthscsa:papaya_viewer:1.0:*:*:*:*:*:*:*
Exploit prediction scoring system (EPSS) score for CVE-2023-33255
0.23%
Probability of exploitation activity in the next 30 days
EPSS Score History
~ 46 %
Percentile, the proportion of vulnerabilities that are scored at or less
CVSS scores for CVE-2023-33255
Base Score | Base Severity | CVSS Vector | Exploitability Score | Impact Score | Score Source | First Seen |
---|---|---|---|---|---|---|
6.1
|
MEDIUM | CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N |
2.8
|
2.7
|
134c704f-9b21-4f2e-91b3-4a467353bcc0 | 2025-01-15 |
6.1
|
MEDIUM | CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N |
2.8
|
2.7
|
NIST |
CWE ids for CVE-2023-33255
-
The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users.Assigned by:
- 134c704f-9b21-4f2e-91b3-4a467353bcc0 (Secondary)
- nvd@nist.gov (Primary)
References for CVE-2023-33255
-
https://www.schutzwerk.com/blog/schutzwerk-sa-2022-001/
Advisory: Cross-Site-Scripting in Papaya Medical Viewer (CVE-2023-33255) - SCHUTZWERK
-
https://schutzwerk.com
Home - SCHUTZWERKNot Applicable
-
http://seclists.org/fulldisclosure/2023/May/21
Full Disclosure: SCHUTZWERK-SA-2022-001: Cross-Site-Scripting in Papaya Medical ViewerExploit;Mailing List;Third Party Advisory
-
https://www.schutzwerk.com/advisories/SCHUTZWERK-SA-2022-001.txt
Third Party Advisory
-
http://packetstormsecurity.com/files/172644/Papaya-Medical-Viewer-1.0-Cross-Site-Scripting.html
Papaya Medical Viewer 1.0 Cross Site Scripting ≈ Packet StormExploit;Third Party Advisory;VDB Entry
Jump to